Brief: Nordic Nanovector Q4 Comprehensive Loss Nok 87.7 Million
Feb 27 (Reuters) - Nordic Nanovector ASA NANOV.OL :
* Q4 REVENUE NOK 0.0 VERSUS NOK 0.05 MILLION YEAR AGO
* Q4 COMPREHENSIVE LOSS NOK 87.7 MILLION VERSUS LOSS NOK 87.6 MILLION YEAR AGO
* CURRENT CASH RESOURCES ARE EXPECTED TO BE SUFFICIENT TO REACH DATA READ-OUT FROM PARADIGME
IN
FIRST HALF OF 2020.
Source text for Eikon: ID:nWkr4CMwXS
Further company coverage: NANOV.OL
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln